Andere talen Avricore Health Inc.

Aandelen

AVCR

CA0545211090

Beurs gesloten - Toronto S.E. Andere beurzen 20:43:41 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,155 ^CAD	+3,33%		+14,81%	-8,82%

30/04	Avricore Health Inc. Rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Avricore Health Inc. Rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Avricore Health Corporate Update and Audited Results for 2023	30/04
Avricore Health Inc. - HealthTab Signs Agreement for More Rexall Pharmacy Locations	05/04
Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations	04/04
HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations	04/04
Avricore Health Provides Update on Q3	30/11
Avricore Health Corporate Update – Company Demonstrates Strong Growth	30/11
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
Avricore Health Inc. - HealthTab Supports Patient Testing in the First Rexall Pharmacy Walk-In Clinic	20-09-23
HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic	15-09-23
Avricore Health Inc. Expands Its Innovative Point-Of-Care Chronic and Infectious Disease Screening and Health- Data Management Platform, Healthtab	15-09-23
Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track	30-08-23
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29-08-23
Avricore's HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom	09-08-23
Avricore Health Inc. - HealthTab Signs Reseller Agreement with Abbott to Support UK Expansion	09-08-23
Avricore Health Up Nearly 14% After Reporting Reseller Pact Between HealthTab, Abbott Rapid Dx UK & Ireland	08-08-23
HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion	08-08-23
Avricore Health Inc. Announces its Agreement with Ascensia Diabetes Care to Integrate Their Blood Glucose Monitoring Systems, Marketed as Contour Next Gen and Four Next One	03-08-23
Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom	03-08-23
Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom	03-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Avricore Health Inc.

Aandelen

AVCR

CA0545211090

Andere talen

Filters